Back
Keros Therapeutics Vs. Eli Lilly and Industry Stock Comparison
Sell
15
KROS
Keros Therapeutics
Last Price:
18.85
Seasonality Move:
14.46%
Sell
45
LLY
Eli Lilly and
Last Price:
789.27
Seasonality Move:
4.05%
Sell
15
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $18.83. The Score for KROS is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
45
Eli Lilly and (LLY)
is a Sell
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $789.12. The Score for LLY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- LLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $18.83
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $789.12
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LLY is experiencing buying pressure, which is a positive indicator for future bullish movement.
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.62 | Sell |
Relative Strength Index (14 RSI): | 22.69 | Sell |
Chaikin Money Flow: | -1326968 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.05 - 70.43) | Sell |
Bollinger Bands (100): | (46.62 - 63.56) | Sell |
LLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.66 | Sell |
Relative Strength Index (14 RSI): | 44.66 | Sell |
Chaikin Money Flow: | 1520610 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (757.23 - 821.11) | Sell |
Bollinger Bands (100): | (800.36 - 929.58) | Sell |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55.22 | Sell |
20-day SMA: | 55.96 | Sell |
50-day SMA: | 59.16 | Sell |
200-day SMA: | 55.11 | Sell |
8-day EMA: | 47 | Sell |
20-day EMA: | 54.67 | Sell |
50-day EMA: | 56.98 | Sell |
200-day EMA: | 53.66 | Sell |
LLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 806.6 | Sell |
20-day SMA: | 782.41 | Buy |
50-day SMA: | 834.74 | Sell |
200-day SMA: | 837.95 | Sell |
8-day EMA: | 796.79 | Sell |
20-day EMA: | 799.24 | Sell |
50-day EMA: | 824.12 | Sell |
200-day EMA: | 809.62 | Sell |
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $0.18 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.92 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.87 per share, and an increase next year of $9.46 per share.
Keros Therapeutics Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Eli Lilly and Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |